July 26, 2019
The Senate Finance Committee on Thursday voted 19-9 to advance a bipartisan bill aimed at lowering prescription drug costs, but the bill might face opposition in the full Senate unless it undergoes substantial revisions.
FDA on Tuesday announced the launch of the agency's first television advertisements intended to educate children about the risks of using e-cigarettes.
The Senate Health, Education, Labor and Pensions Committee's top Republican and Democratic members on Wednesday said the full Senate would not take up the committee's legislative package to address so-called "surprise" medical bills before Congress' August recess.
American Health Line rounds up the latest health care news in the states.
July 25, 2019
HHS Secretary Alex Azar on Tuesday laid out three of the Trump administration's top health care priorities heading into the 2020 election.
In 2016, a number of United States diplomats in Cuba began experiencing symptoms—including headaches, blurred vision, and hearing phantom sounds—that have yet to be explained, and now, a new study shows changes in the diplomats' brains.
Allergan on Wednesday announced a global recall of the company's Biocell textured breast implants, after FDA found a link between the implants and a sharp increase in cases of and deaths involving a rare cancer.
A federal judge who earlier this year struck down Medicaid work requirements in Arkansas and Kentucky on Tuesday heard oral arguments in a lawsuit challenging the Trump administration's approval of Medicaid work requirements in New Hampshire, but it is unclear how the judge will rule in the latest case.
July 24, 2019
Senate Finance Committee Chair Chuck Grassley (R-Iowa) and Sen. Ron Wyden (D-Ore.), the ranking member on the committee, on Tuesday introduced a sweeping bill aimed at lowering prescription drug costs by changing various Medicare and Medicaid policies, but the bill quickly drew criticism from congressional Republicans and the pharmaceutical industry.
Major issues at Indian Health Service hospitals have led to unsafe conditions for patients, risky opioid prescribing practices, and information technology vulnerabilities, according to two reports released Monday by HHS' Office of Inspector General.
Advisory Board. All rights reserved.